172. Cancer Biomark. 2018;22(3):523-531. doi: 10.3233/CBM-181185.The correlation between mammographic densities and molecular pathology in breast cancer.Ji Y, Shao Z, Liu J, Hao Y, Liu P.This study aimed to analyze the correlation between mammographic density obtainedby density analysis software (DAS)/radiologists visual (RV) classification withmolecular subtype, and the expression levels of estrogen receptor (ER),progesterone receptor (PR), Ki67 antigen (Ki-67), p53 gene (p53), and humanepidermal growth factor receptor-2 (HER2). A total of 688 breast cancer patients with digital mammography and complete molecular pathological results in TianjinMedical University Cancer Institute and Hospital between February 2015 andFebruary 2016 were collected. The DAS-density grade (DASD) and the radiologistsvisually classified density grade (RVD) were evaluated by 3 radiologists. Thecorrelation between density grade and the expression levels of ER, PR, Ki-67,p53, HER2 and breast cancer molecular subtype (PMS) were analyzed. The agreement between DASD and RVD was explored. ER, PR and HER-2 positive rate weresignificantly different among patients with different RVD grades (P< 0.05). HER2 positive rates showed an increasing trend following RVD upgrading (Pð‘¡ð‘Ÿð‘’ð‘›ð‘‘< 0.05).HER-2 positive rate in RVD D1 + D2 was 7.69%, which was higher than that in D3 + D4 (P< 0.05). The ER and Ki-67 expressions in patients were markedly differentamong DASD (P= 0.009 and 0.002) and RVD (P= 0.012 and 0.036) with differentgrades. The kappa value of each DASD to RVD was 0.31 (P< 0.01). The RVD 3proportion was 14.58% (63/432) in HER2 Over-expressing subtype, which wasapparently higher than RVD1 (2.43%, 1/41) (P< 0.05). Breast density may bepartial correlated with molecular pathology in breast cancer.DOI: 10.3233/CBM-181185 PMID: 29843215 